Myasthenia Gravis

2024 AANEM Conference Summary Featuring Dianna Quan, MD, 2024 AANEM President, Donald Sanders, MD, and Janice Massey, MD, Duke University School of Medicine

Conference KOL Highlights

2024 AANEM Conference Summary Featuring Dianna Quan, MD, 2024 AANEM President, Donald Sanders, MD, and Janice Massey, MD, Duke University School of Medicine

Oct 24, 2024

4 min read

FDA Approves Zilbrysq for Generalized Myasthenia Gravis

Physician’s Briefing

FDA Approves Zilbrysq for Generalized Myasthenia Gravis

Oct 24, 2023

1 min read

FDA Approves Subcutaneous Vyvgart Hytrulo for Generalized Myasthenia Gravis

FDA Approves Subcutaneous Vyvgart Hytrulo for Generalized Myasthenia Gravis

Jun 27, 2023

1 min read

FDA Approves First-in-Class Treatment for Myasthenia Gravis

FDA Approves First-in-Class Treatment for Myasthenia Gravis

Physician’s Briefing Staff

Dec 21, 2021

1 min read

image-fallback

Oral Antisense Drug May Benefit Myasthenia Gravis

Aug 14, 2007

1 min read

image-fallback

Myasthenia Gravis Makes Pregnancy Risky

Nov 24, 2003

1 min read

www.healthday.com